Syros Pharmaceuticals Inc (SYRS): Institutional Ownership
Hedge funds and institutional managers reporting a position in SYRS. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$4.7M
Across holders
Last Price
$0.00
2026-06-26
Sector
—
GICS
Holder activity5 new0 added0 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. CIK 0001165408 | Hedge Fund | 2.07M | $4.5M | 94.3% | 0.0% | New | — | Q3 2024 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 23K | $124K | 2.6% | 0.0% | New | — | Q1 2024 |
| Brevan Howard Capital Management LP CIK 0001512857 | Hedge Fund | 16K | $86K | 1.8% | 0.0% | New | — | Q1 2024 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 210K | $48K | 1.0% | 0.0% | New | — | Q4 2024 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 49K | $11K | 0.2% | 0.0% | New | — | Q4 2024 |
New
Hedge Fund
$4.5M· 94.3% of total· 0.0% port· 2.07M sh· — QoQ· Q3 2024
New
Hedge Fund
$124K· 2.6% of total· 0.0% port· 23K sh· — QoQ· Q1 2024
New
Hedge Fund
$86K· 1.8% of total· 0.0% port· 16K sh· — QoQ· Q1 2024
New
Hedge Fund
$48K· 1.0% of total· 0.0% port· 210K sh· — QoQ· Q4 2024
New
Hedge Fund
$11K· 0.2% of total· 0.0% port· 49K sh· — QoQ· Q4 2024